Manufacturers use several different ways of naming their products and for communicating its content. Some use a percentage for the concentration, where 5% CBD actually doesn’t mean 5mg/ml but 50mg/ml because one always works back
Check out what we have to say.
Patients with certain chronic conditions should rightly be concerned about the outbreak of Covid-19. Many of the patients we work with at Logist fall into the more vulnerable groups with regards to the threat from
In a world dominated by Corona virus, self-isolation, lock-downs and stockpiling, first of all it is important to state that cannabis medicines are as accessible as ever. Based on a recent YouGov poll there are
The use of telecommunication techniques in the healthcare sector has gained traction in the past two decades. However, never before has the need for remote access to healthcare been so critically apparent to the wider
Grow Biotech, Logist and IPS are ready to help patients who are having issues with supply of cannabis medicines due to Covid-19. We are asking those in need to inform their prescribing physician to get
There have been murmurings it seems, across many areas of the UK healthcare landscape in the last year, around cannabis medicines. A media hot topic, this ancient plant has been receiving more focus than ever
Logist pharma was set up to support access to cannabis medicines for those who need it. We specialise in education and support for healthcare professionals to help them navigate the system and understand what role
On 14th February 2019 Logist Pharma facilitated the first bulk import of cannabis medicines into the UK. One year on from this momentous milestone we have been spending some time speaking directly to patients, some
After successfully fulfilling multiple prescriptions with the UK’s first bulk import of medicinal cannabis, and importing an array of different products shortly after, we established an integrated solution with our partner IPS Pharma, incorporating Logist Pharma in April this year. There have been exciting developments in the UK medical cannabis sector since the medication’s rescheduling in November 2018. However, it hasn’t been without its challenges.
- Page 1 of 2